Regeneration Takes Center StageThis year, Cosmetic 360 places regeneration at the heart of its conference programme, inviting the cosmetic industry to move beyond sustainability toward practices that actively repair, restore, and revitalize. It’s a theme that sits at the very core of our own science: regeneration begins when tissue homeostasis is restored, a balance progressively lost as tissues age. Tomorrow’s most effective cosmetic actives won’t be the ones that shift isolated biomarkers; they will be the ones capable of reactivating coordinated tissue repair.
What We’re PresentingOur talk, « A human ex vivo integrative platform for predictive tissue regeneration and longevity approaches, » will take place in Session 5 – Testing & Analysis – Decoding Regeneration: From Ambition to Proof, on October 15th at 3:20 PM, presented by Vincent Dani, Co-founder & CEO of ExAdEx-Innov.
We’ll introduce the platform behind ExAdEx Longevity Lab: a human ex vivo system that screens active compounds against nearly 30 biomarkers spanning the key hallmarks of ageing — inflammaging, senescence, mitochondrial dysfunction, extracellular matrix remodeling, oxidative stress, and regenerative capacity — in a physiologically relevant tissue setting. These multiparametric readouts are condensed into a single tissue regeneration score: a predictive way to identify broad-spectrum actives with genuine biological coherence, and even to estimate synergistic effects between ingredient combinations.
From Screening to Science-Based ClaimsBy linking predictive ex vivo analysis with the biology of regeneration, ExAdEx Longevity Lab offers a translational engine to prioritize next-generation formulations and active ingredients according to their real capacity to restore tissue function as a whole — helping bridge the gap between early screening and substantiated, science-based claims.
Join Us at Cosmetic 360
Session 5 – Testing & Analysis – Decoding Regeneration: From Ambition to Proof
October 15, 2026 – 3:20 PM
Speaker: Vincent Dani, Co-founder & CEO
Carrousel du Louvre, Paris (France)
Free access, no reservation required (Conferences Room)
See the full Cosmetic 360 conference programme, and discover our Longevity Lab online.
The United States Patent and Trademark Office has granted a U.S. patent covering the ExAdEx core technology: a major milestone for our intellectual property portfolio
ExAdEx-Innov launches its Longevity Lab: a new platform for tissue and metabolic longevity ExAdEx‑Innov is proud to announce the launch of the Longevity Lab, a
Understanding and countering facial tissue effects with our unique donor ex vivo models The rise of GLP-1 agonists is revolutionizing obesity management, but has revealing
Copyright © 2022 ExAdEx-Innov All rights reserved
KOL on adipose tissue biology.
Research Director (DR1 INSERM).
Team Leader of « Stem Cells and Differentiation » Lab at Institut de Biologie Valrose (Nice).
Label of Laboratoire d’Excellence by the French National Research Agency (Investissements pour le Futur, Labex Signalife program).
Co-inventor of 5 patents
Expert in clinical applications of adipose tissue.
Plastic Reconstructive and Aesthetic Surgeon in Nice.
Member of the Medical Council of Alpes Maritimes region.
Expert for the French National Regulatory Agency ANSM for medical devices.
Certified by French Health Autority HAS (2020-2024).
PhD thesis (2018) on fat tissue and adipose tissue stem cells grafting.
Expert in cell therapy and immunology.
Senior Lecturer (Maitre de conférences).
Responsible of the Cell and Gene Therapy Unity of Nice University Hospital (CHU de Nice).
Director of « Micoralis » research team at Université Côte d’Azur (Nice).
Founder and CEO of the biotech company Biointerférence (2003-2006).
Co-inventor of 5 patents.
Vincent is responsible of company strategy and technological innovation, thanks to his double skill set in science and deeptech startup development.
With a deep knowledge and vision about ExAdEx technology, Vincent has actively worked as a deeptech entrepreneur to push further the development of breakthrough innovative products around human adipose tissue, which lead him to create ExAdEx-Inov.
In addition to his entrepreneurial skills, Vincent has a strong background in biology (PhD in Cellular and Molecular Biology from Université Côte d’Azur) and training in clinical research management (CRA training at the Faculty of Medicine of La Timone, Marseille).
He is co-inventor of the 2 company’s patent families.
Main areas of expertise: DeepTech entrepreneur; Bioengineering of human adipose tissue.
Luigi is responsible of the management of company operations and business development strategy, thanks to his expertise in biotech startup development.
With a double competence and training in business and science (including an MBA from IAE Paris Sorbonne Business School and a PhD in Cytological Sciences from Rome University La Sapienza), Luigi has been managing business development and R&D projects in a preclinical CRO and a biotech startup company in previous years.
He has been supporting ExAdEx-Innov project and business development since his position as an Entrepreneur in Residence for CNRS Innovation Tech Transfer Office in 2021.
Main areas of expertise: Biotech Startup Business Development; Project management
